{"id":"NCT04530344","sponsor":"Incyte Corporation","briefTitle":"Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo","officialTitle":"A Double-Blind, Vehicle-Controlled, Randomized Withdrawal and Treatment Extension Study to Assess the Long-Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-09-24","primaryCompletion":"2022-11-14","completion":"2022-11-14","firstPosted":"2020-08-28","resultsPosted":"2023-07-19","lastUpdate":"2025-08-14"},"enrollment":458,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Vitiligo"],"interventions":[{"type":"DRUG","name":"ruxolitinib","otherNames":["INCB018424 Cream"]},{"type":"DRUG","name":"Vehicle","otherNames":[]}],"arms":[{"label":"Cohort A : ruxolitinib cream","type":"EXPERIMENTAL"},{"label":"Cohort A : Vehicle","type":"PLACEBO_COMPARATOR"},{"label":"Cohort B : roxolitinib cream","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the duration of response following withdrawal of ruxolitinib cream (Cohort A vehicle group), safety and maintenance of response with continued use of ruxolitinib cream in participants who have completed either Study NCT04052425 or NCT04057573 (parent studies) in which the participants will have been using ruxolitinib cream BID for the previous 28 to 52 weeks depending on their initial randomization in the parent study.","primaryOutcome":{"measure":"Time to Relapse (Defined as <F-VASI75)","timeFrame":"from Week 52 (first visit of this Treatment Extension study) to Week 104 (end of treatment in this Treatment Extension study)","effectByArm":[{"arm":"Cohort A: Vehicle Cream BID","deltaMin":null,"sd":null},{"arm":"Cohort A: Ruxolitinib 1.5% Cream BID","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0414"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":4},"locations":{"siteCount":84,"countries":["United States","Bulgaria","Canada","France","Germany","Netherlands","Poland","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":58},"commonTop":["COVID-19"]}}